Tina M. Albertson

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Barbara G. McClung, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tina M. Albertson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Caribou Biosciences, Inc. Chief Medical Officer Common Stock 68,523 $134,305 $1.96 24 Feb 2026 Direct
Lyell Immunopharma, Inc. Chief Medical Officer Common Stock 4,049 $9,232 $2.28 24 Feb 2023 Direct
Lyell Immunopharma, Inc. Chief Medical Officer Option (right to buy) 700,000 24 Feb 2023 Direct
Caribou Biosciences, Inc. Chief Medical Officer Option to purchase Common Stock 247,500 20 Feb 2026 Direct

Insider Reports Filed by Tina M. Albertson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBU Caribou Biosciences, Inc. 20 Feb 2026 3 -$2,089 4 Chief Medical Officer 24 Feb 2026, 20:53
CRBU Caribou Biosciences, Inc. 20 Feb 2025 2 $0 4 Chief Medical Officer 21 Feb 2025, 20:20
CRBU Caribou Biosciences, Inc. 19 Aug 2024 1 $0 4 Chief Medical Officer 20 Aug 2024, 16:07
CRBU Caribou Biosciences, Inc. 12 Aug 2024 0 $0 3 Chief Medical Officer 20 Aug 2024, 16:05
LYEL Lyell Immunopharma, Inc. 24 Feb 2023 1 $0 4 Chief Medical Officer 28 Feb 2023, 17:19
LYEL Lyell Immunopharma, Inc. 23 Mar 2022 0 $0 3 Chief Medical Officer 29 Mar 2022, 17:05